title: Endothelial nitric oxide synthase gene interactions and the risk of ischaemic stroke.
abstract: OBJECTIVE
  Endothelial nitric oxide synthase (eNOS), which produces NO, plays an important role in the endothelial function under a wide range of physiological conditions. eNOS exon 7 polymorphism (Glu298Asp, G894T) has been considered to influence the risk of coronary artery disease. Alone, however, it has not been shown to be a genetic risk factor for ischaemic stroke. With the assumption of additive interactions, we examined whether the eNOS G894T or eNOS 894TT genotypes in combination with the methylenetetrahydrofolate reductase 677TT (MTHFR 677TT) or angiotensin-converting enzyme (ACE) D/D genotype could contribute to acute ischaemic stroke.
  
  
  METHODS
  The data on 407 consecutive patients with acute ischaemic stroke who had never suffered a previous stroke event were analysed. As a control group, 295 stroke and neuroimaging alteration-free Caucasian subjects were examined. With the use of the PCR technique, the eNOS G894T, eNOS 894TT, MTHFR 677TT and ACE D/D mutations, as unfavourable common genotypes were determined in the participants. Logistic regression models were used to evaluate the roles of the genotypes and their combinations in the development of ischaemic stroke.
  
  
  RESULTS
  The MTHFR C677TT genotype combined with the eNOS G894T or eNOS 894TT genotypes occurred significantly more frequently in the subjects with ischaemic stroke (7.1%; P < 0.025) than in the control group (3.1%). The co-occurrence of the ACE D/D genotype and eNOS G894T or eNOS 894TT was calculated to be more frequent in the ischaemic stroke group (20.9%, P < 0.0001) than in the control group (5.4%).
  
  
  CONCLUSIONS
  The eNOS G894T or eNOS 894TT genotypes in combination with the MTHFR 677TT or ACE D/D genotype increases the risk of ischaemic stroke.
authors.affiliation: Department of Neurology and Neurophysiology, Pándy Kálmán County Hospital, Gyula, Hungary. szolnoki99@hotmail.com
authors.forename: Z
authors.initials: Z
authors.lastname: Szolnoki
authors.forename: V
authors.initials: V
authors.lastname: Havasi
authors.forename: J
authors.initials: J
authors.lastname: Bene
authors.forename: K
authors.initials: K
authors.lastname: Komlósi
authors.forename: D
authors.initials: D
authors.lastname: Szöke
authors.forename: F
authors.initials: F
authors.lastname: Somogyvári
authors.forename: A
authors.initials: A
authors.lastname: Kondacs
authors.forename: M
authors.initials: M
authors.lastname: Szabó
authors.forename: L
authors.initials: L
authors.lastname: Fodor
authors.forename: A
authors.initials: A
authors.lastname: Bodor
authors.forename: I
authors.initials: I
authors.lastname: Gáti
authors.forename: I
authors.initials: I
authors.lastname: Wittman
authors.forename: B
authors.initials: B
authors.lastname: Melegh
mesh_terms: D000368:Aged; D002545:Brain Ischemia / Q000453:epidemiology* / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease / Q000453:epidemiology; D006801:Humans; D008297:Male; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics; D008875:Middle Aged; D019001:Nitric Oxide Synthase / Q000235:genetics*; D052250:Nitric Oxide Synthase Type III; D007703:Peptidyl-Dipeptidase A / Q000235:genetics; D012307:Risk Factors; D020521:Stroke / Q000453:epidemiology* / Q000235:genetics*
chemical_list: C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D007703:Peptidyl-Dipeptidase A